Caffeine in the Second Stage of Labor in Low-risk Nulliparous Mothers at Term

Status unconfirmed · Phase 1 · Has a placebo group

Conditions studied: Second Stage of Labor

In brief

Single blind, randomized control trial to determine benefit of caffeine and sodium benzoate on the second stage of labor

Key facts

Study ID

NCT05906303

Run by

The Reading Hospital and Medical Center

People needed

80

Starts

2023-12-01

Expected to finish

2025-02-01

Last updated by the study team

2023-09-14

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Nulliparous pregnant mothers at term (37 weeks gestation and above), 18-45 years of age, intravenous access. Patients receiving prenatal care at Tower Health Obstetrical practices.

You may not qualify if…

• Hypertensive disorders (chronic hypertension, gestation hypertension, pre-eclampsia, HELLP syndrome; hypertension defined as a systolic blood pressure of 140 mmHg or diastolic blood pressure of 90 mmHg collected on two occasions four hours apart. Upon a new diagnosis of gestational hypertension, the patients would then be excluded. Chronic hypertensive patients are excluded by default.), significant cardiac history (history of myocardial infarction, stroke, arrhythmias, cardiomyopathy), positive drug screen on admission for cocaine or amphetamines (to be performed per hospital policy and provider discretion), fetal malpresentation, hepatic impairment to include a known history of fatty liver disease, cirrhosis or previously documented abnormal liver function testing (AST >39, ALT >52) or lack of prenatal care.

Where it is running

• Reading Hospital Labor & Delivery — West Reading, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.